Literature DB >> 35639278

Let-7c-5p Restrains Cell Growth and Induces Apoptosis of Lung Adenocarcinoma Cells via Targeting ESPL1.

Xiang Liu1, Wei Zeng1, Dayang Zheng1, Min Tang1, Wangyan Zhou2.   

Abstract

Lung adenocarcinoma (LUAD) is a predominant malignancy, and its high mortality prompts us to incessantly probe the relevant targeted treatment. This work intended to study the molecular mechanism of ESPL1 in LUAD. Bioinformatics analysis was performed for pan-cancer and prognosis analysis as well as target gene prediction. Expression of ESPL1 mRNA and let-7c-5p was determined via qRT-PCR, and western blot was employed to detect protein level of ESPL1. Dual-luciferase reporter gene method verified the interaction between ESPL1 and let-7c-5p. Thereafter, CCK-8, wound healing, Transwell, and flow cytometry assays were utilized to investigate proliferation, migration, and apoptosis of LUAD cells. The results revealed that ESPL1 was upregulated in LUAD, which was associated with poor prognosis. Overexpressed ESPL1 promoted LUAD cells to invade, proliferate, and migrate. Furthermore, ESPL1 was a target gene of let-7c-5p. Let-7c-5p was downregulated in LUAD cells, and played a suppressive role in LUAD malignant development, while reversed by ESPL1. Taken together, it was posited that let-7c-5p/ESPL1 may be underlying therapeutic targets of LUAD.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Apoptosis; ESPL1; Invasion; LUAD; Let-7c-5p; Migration; Proliferation

Mesh:

Substances:

Year:  2022        PMID: 35639278     DOI: 10.1007/s12033-022-00511-2

Source DB:  PubMed          Journal:  Mol Biotechnol        ISSN: 1073-6085            Impact factor:   2.860


  26 in total

Review 1.  Secured cutting: controlling separase at the metaphase to anaphase transition.

Authors:  F Uhlmann
Journal:  EMBO Rep       Date:  2001-06       Impact factor: 8.807

Review 2.  Cohesin: its roles and mechanisms.

Authors:  Kim Nasmyth; Christian H Haering
Journal:  Annu Rev Genet       Date:  2009       Impact factor: 16.830

Review 3.  Lung cancer stem cells: origin, features, maintenance mechanisms and therapeutic targeting.

Authors:  Win Sen Heng; Reinoud Gosens; Frank A E Kruyt
Journal:  Biochem Pharmacol       Date:  2018-12-14       Impact factor: 5.858

4.  Expression profile of MicroRNAs in young stroke patients.

Authors:  Kay Sin Tan; Arunmozhiarasi Armugam; Sugunavathi Sepramaniam; Kai Ying Lim; Karolina Dwi Setyowati; Chee Woon Wang; Kandiah Jeyaseelan
Journal:  PLoS One       Date:  2009-11-02       Impact factor: 3.240

5.  Annual report to the nation on the status of cancer, part I: National cancer statistics.

Authors:  S Jane Henley; Elizabeth M Ward; Susan Scott; Jiemin Ma; Robert N Anderson; Albert U Firth; Cheryll C Thomas; Farhad Islami; Hannah K Weir; Denise Riedel Lewis; Recinda L Sherman; Manxia Wu; Vicki B Benard; Lisa C Richardson; Ahmedin Jemal; Kathleen Cronin; Betsy A Kohler
Journal:  Cancer       Date:  2020-03-12       Impact factor: 6.921

6.  miR-27a regulates cisplatin resistance and metastasis by targeting RKIP in human lung adenocarcinoma cells.

Authors:  Jipeng Li; Yiping Wang; Yulan Song; Zhongming Fu; Wanjun Yu
Journal:  Mol Cancer       Date:  2014-08-16       Impact factor: 27.401

Review 7.  Progress and prospects of early detection in lung cancer.

Authors:  Sean Blandin Knight; Phil A Crosbie; Haval Balata; Jakub Chudziak; Tracy Hussell; Caroline Dive
Journal:  Open Biol       Date:  2017-09       Impact factor: 6.411

8.  miR-944 inhibits lung adenocarcinoma tumorigenesis by targeting STAT1 interaction.

Authors:  Jing Chun An; Han-Bing Shi; Wen-Bo Hao; Kun Zhu; Bo Ma
Journal:  Oncol Lett       Date:  2019-02-18       Impact factor: 2.967

Review 9.  [Lung Cancer Stem-like Cells and Drug Resistance].

Authors:  Zhenhua Pan; Hongyu Liu; Jun Chen
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2022-02-20

10.  MMTV-Espl1 transgenic mice develop aneuploid, estrogen receptor alpha (ERα)-positive mammary adenocarcinomas.

Authors:  Malini Mukherjee; Gouqing Ge; Nenggang Zhang; David G Edwards; Pavel Sumazin; Shyam K Sharan; Pulivarthi H Rao; Daniel Medina; Debananda Pati
Journal:  Oncogene       Date:  2013-11-25       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.